Information de reference pour ce titreAccession Number: | 00006374-200625510-00011.
|
Author: | Basseres, D S; Baldwin, A S
|
Institution: | Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA
|
Title: | Nuclear factor-[kappa]B and inhibitor of [kappa]B kinase pathways in oncogenic initiation and progression.[Review]
|
Source: | Oncogene. 25(51):6817-6830, October 30, 2006.
|
Abstract: | Abundant data support a key role for the transcription factor nuclear factor-[kappa]B (NF-[kappa]B) signaling pathway in controlling the initiation and progression of human cancer. NF-[kappa]B and associated regulatory proteins such as I[kappa]B kinase (IKK) are activated downstream of many oncoproteins and there is much evidence for the activation of NF-[kappa]B-dependent target genes in a variety of solid tumors and hematologic malignancies. This review focuses on the mechanisms by which the NF-[kappa]B pathway is activated in cancer and on the oncogenic functions controlled by activated NF-[kappa]B. Additionally, the effects of NF-[kappa]B activation in tumors relative to cancer therapy are also discussed.
Copyright (C) 2006 Nature Publishing Group
|
Author Keywords: | NF-[kappa]B; IKK; cancer; cancer therapy; inhibitors; signal transduction.
|
References: | Adli M, Baldwin AS. (2006). J Biol Chem [Epub ahead of print].
Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, Hughes J et al. (2003). Mol Biol Cell 14: 585-599.
Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. (2002). Carcinogenesis 23: 143-150.
Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS, Sonenshein GE. (2000). Mol Cell Biol 20: 5381-5391.
Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA. (2004). Oncogene 23: 8571-8580.
Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB. (2004). Biochem Pharmacol 67: 353-364.
Baldwin AS. (2001). J Clin Invest 107: 241-246.
Balkwill F, Charles KA, Mantovani A. (2005). Cancer Cell 7: 211-217.
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W et al. (1997). J Clin Invest 100: 2961-2969.
Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M et al. (2002). Leukemia 16: 2062-2071.
Biswas DK, Cruz AP, Gansberger E, Pardee AB. (2000). Proc Natl Acad Sci USA 97: 8542-8547.
Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB et al. (2004). Proc Natl Acad Sci USA 101: 10137-10142.
Bowman T, Garcia R, Turkson J, Jove R. (2000). Oncogene 19: 2474-2488.
Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F et al. (2006). Blood 107: 1156-1165.
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C et al. (1999). Cell 98: 295-303.
Bubici C, Papa S, Dean K, Franzoso G. (2006). Oncogene 25: 6731-6748.
Burstein E, Duckett CS. (2003). Curr Opin Cell Biol 15: 732-737.
Campbell KJ, Rocha S, Perkins ND. (2004). Mol Cell 13: 853-865.
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R et al. (1999). Immunity 10: 105-115.
Chauhan D, Catley L, Li G, Podar K, Hideshima T, Velankar M et al. (2005). Cancer Cell 8: 407-419.
Chen G, Bhojani MS, Heaford AC, Chang DC, Laxman B, Thomas DG et al. (2005). Proc Natl Acad Sci USA 102: 12507-12512.
Cilloni D, Messa F, Arruga F, Defilippi I, Morotti A, Messa E et al. (2006). Leukemia 20: 61-67.
Clevers H. (2004). Cell 118: 671-674.
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS. (2000). Oncogene 19: 1123-1131.
Courtois G, Gilmore TD. (2006). Oncogene 25: 6831-6843.
Coussens LM, Werb Z. (2002). Nature 420: 860-867.
Cusack Jr JC, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J et al. (2001). Cancer Res 61: 3535-3540.
Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ et al. (2003). Nature 421: 639-643.
Dhawan P, Richmond A. (2002). J Biol Chem 277: 7920-7928.
Dhawan P, Singh AB, Ellis DL, Richmond A. (2002). Cancer Res 62: 7335-7342.
Downward J. (2004). Semin Cell Dev Biol 15: 177-182.
Dutta J, Fan Y, Gupta N, Fan G, Gelinas C. (2006). Oncogene 25: 6800-6816.
Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC et al. (2005). Cancer Res 65: 11375-11383.
Farhana L, Dawson MI, Fontana JA. (2005). Cancer Res 65: 4909-4917.
Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari Jr AW et al. (2005). Cancer Res 65: 6294-6304.
Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R et al. (2005). Cancer Cell 7: 39-49.
Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin Jr AS. (1997). J Biol Chem 272: 24113-24116.
Frelin C, Imbert V, Griessinger E, Peyron AC, Rochet N, Philip P et al. (2005). Blood 105: 804-811.
Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL et al. (2003). Clin Cancer Res 9: 346-354.
Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D. (1993). Genes Dev 7: 1354-1363.
Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ. (2000). J Immunol 164: 2200-2206.
Garcea G, Dennison AR, Steward WP, Berry DP. (2005). Pancreatology 5: 514-529.
Garcia MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E. (2005). Leukemia Res 29: 1425-1434.
Gilmore TD. (2006). Oncogene 25: 6680-6684.
Gilmore TD and Herscovitch M. (2006). Oncogene 25: 6887-6899.
Grandage VL, Gale RE, Linch DC, Khwaja A. (2005). Leukemia 19: 586-594.
Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). Cell 118: 285-296.
Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q et al. (2004). J Biol Chem 279: 1615-1620.
Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS et al. (2005). Blood 105: 4163-4169.
Hammerman PS, Fox CJ, Cinalli RM, Xu A, Wagner JD, Lindsten T et al. (2004). Cancer Res 64: 8341-8348.
Hanahan D, Weinberg RA. (2000). Cell 100: 57-70.
Hanson JL, Hawke NA, Kashatus D, Baldwin AS. (2004). Cancer Res 64: 7248-7255.
Hayden MS, Ghosh S. (2004). Genes Dev 18: 2195-2224.
Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC et al. (2001). Oncogene 20: 4917-4925.
Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C. (2001). Blood 97: 2798-2807.
Hiscott J, Nguyen T-LA, Arguello M, Nakhaei P, Paz S. (2006). Oncogene 25: 6844-6867.
Ho WC, Dickson KM, Barker PA. (2005). Cancer Res 65: 4273-4281.
Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al. (2004). Cell 117: 225-237.
Huang S, Deguzman A, Bucana CD, Fidler IJ. (2000a). Clin Cancer Res 6: 2573-2581.
Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD et al. (2002). Am J Pathol 161: 125-134.
Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. (2000b). Cancer Res 60: 5334-5339.
Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H et al. (2004a). J Clin Invest 114: 569-581.
HuberMA, Beug H, Wirth T. (2004b). Cell Cycle 3: 1477-1480.
Ikenoue T, Hikiba Y, Kanai F, Tanaka Y, Imamura J, Imamura T et al. (2003). Cancer Res 63: 8132-8137.
Jiang Y, Cui L, Yie TA, Rom WN, Cheng H, Tchou-Wong KM. (2001). Oncogene 20: 2254-2263.
Jin F, Liu X, Zhou Z, Yue P, Lotan R, Khuri FR et al. (2005). Cancer Res 65: 6354-6363.
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. (2003). FASEB J 17: 2115-2117.
Kalaitzidis D, Gilmore TD. (2005). Trends Endocrinol Metab 16: 46-52.
Karin M. (2006). Nature 441: 431-436.
Karin M, Cao Y, Greten FR, Li ZW. (2002). Nat Rev Cancer 2: 301-310.
Kashatus D, Cogswell P, Baldwin AS. (2006). Genes Dev 20: 225-235.
Keifer JA, Guttridge DC, Ashburner BP, Baldwin Jr AS. (2001). J Biol Chem 276: 22382-22387.
Kim HJ, Hawke N, Baldwin AS. (2006). Cell Death Differ 13: 738-747.
Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C et al. (2005a). Nature 434: 921-926.
Kim JH, Liu L, Lee SO, Kim YT, You KR, Kim DG. (2005b). Cancer Res 65: 6312-6320.
Kirchner D, Duyster J, Ottmann O, Schmid RM, Bergmann L, Munzert G. (2003). Exp Hematol 31: 504-511.
Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. (2000). Leukemia 14: 399-402.
Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. (2003). Nature 424: 801-805.
Kucharczak J, Simmons MJ, Fan Y, Gelinas C. (2003). Oncogene 22: 8961-8982.
Lam LT, Davis RE, Pierce J, Hepperle M, Xu Y, Hottelet M B et al. (2005). Clin Cancer Res 11: 28-40.
Landowski TH, Megli CJ, Nullmeyer KD, Lynch RM, Dorr RT. (2005). Cancer Res 65: 3828-3836.
Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM. (2003). Int J Cancer 105: 735-746.
Luo JL, Kamata H, Karin M. (2005). J Clin Invest 115: 2625-2632.
Maeda S, Kamata H, Luo JL, Leffert H, Karin M. (2005). Cell 121: 977-990.
Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R. (2006). Cell 125: 665-677.
Mathas S, Lietz A, Janz M, Hinz M, Jundt F, Scheidereit C et al. (2003). Blood 102: 1028-1034.
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ et al. (1997). Science 278: 1812-1815.
Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X et al. (2002a). Proc Natl Acad Sci USA 99: 14374-14379.
Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T et al. (2002b). Blood 99: 4525-4530.
Mrowietz U, Schwenk U, Maune S, Bartels J, Kupper M, Fichtner I et al. (1999). Br J Cancer 79: 1025-1031.
Muerkoster S, Arlt A, Sipos B, Witt M, Grossmann M, Kloppel G et al. (2005). Cancer Res 65: 1316-1324.
Muerkoster S, Wegehenkel K, Arlt A, Witt M, Sipos B, Kruse ML et al. (2004). Cancer Res 64: 1331-1337.
Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. (2001). Oncogene 20: 7597-7609.
Munzert G, Kirchner D, Ottmann O, Bergmann L, Schmid RM. (2004). Leukemia Lymphoma 45: 1181-1184.
Nadiminty N, Lou W, Lee SO, Lin X, Trump DL, Gao AC. (2006). Proc Natl Acad Sci USA 103: 7264-7269.
Nakanishi C, Toi M. (2005). Nat Rev Cancer 5: 297-309.
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW. (1997). Mol Cell Biol 17: 3629-3639.
Nakshatri H, Rice SE, Bhat-Nakshatri P. (2004). Oncogene 23: 7330-7344.
Nasr R, El-Sabban ME, Karam JA, Dbaibo G, Kfoury Y, Arnulf B et al. (2005). Oncogene 24: 419-430.
Nawata R, Yujiri T, Nakamura Y, Ariyoshi K, Takahashi T, Sato Y et al. (2003). Oncogene 22: 7774-7780.
Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G et al. (2006). Nature 441: 106-110.
Ni H, Ergin M, Huang Q, Qin JZ, Amin HM, Martinez RL et al. (2001). Br J Haematol 115: 279-286.
Niu J, Li Z, Peng B, Chiao PJ. (2004). J Biol Chem 279: 16452-16462.
Orlowski RZ, Baldwin Jr AS. (2002). Trends Mol Med 8: 385-389.
Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. (2005). Cancer Res 65: 2076-2081.
Palmby TR, Abe K, Karnoub AE, Der CJ. (2004). Mol Cancer Res 2: 702-711.
Perkins ND. (2004). Trends Cell Biol 14: 64-69.
Perkins ND. (2006). Oncogene 25: 6717-6730.
Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. (2001). Oncogene 20: 1287-1299.
Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. (2004). Nature 431: 461-466.
Rajkumar SV. (2003). Semin Hematol 40: 17-22.
Ramaswamy S, Perou CM. (2003). Lancet 361: 1576-1577.
Rayet B, Gelinas C. (1999). Oncogene 18: 6938-6947.
Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin Jr AS. (1998). Genes Dev 12: 968-981.
Richardson PG, Hideshima T, Mitsiades C, Anderson K. (2004). Ann Med 36: 304-314.
Robe PA, tires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H et al. (2004). Clin Cancer Res 10: 5595-5603.
Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. (2005). EMBO J 24: 1157-1169.
Romashkova JA, Makarov SS. (1999). Nature 401: 86-90.
Romieu-Mourez F, Kim DW, SHin SM, Demicco EG, Landesman-Bollag E, Seldin DC et al. (2002). Mol Cell Biol 23: 5738-5754.
Russo SM, Tepper JE, Baldwin Jr AS, Liu R, Adams J, Elliott P et al. (2001). Int J Radiat Oncol Biol Phys 50: 183-193.
Ryan KM, Ernst MK, Rice NR, Vousden KH. (2000). Nature 404: 892-897.
Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G et al. (2003). Mol Cell 12: 1413-1426.
Scheidereit C. (2006). Oncogene 25: 6685-6705.
Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM et al. (2006). Int J Cancer 118: 2405-2411.
Shishodia S, Aggarwal BB. (2004). Biochem Pharmacol 68: 1071-1080.
Shishodia S, Amin HM, Lai R, Aggarwal BB. (2005). Biochem Pharmacol 70: 700-713.
Shishodia S, Koul D, Aggarwal BB. (2004). J Immunol 173: 2011-2022.
Singh RK, Varney ML, Bucana CD, Johansson SL. (1999). Melanoma Res 9: 383-387.
Sitcheran R, Gupta P, Fisher PB, Baldwin AS. (2005). EMBO J 24: 510-520.
Small GW, Shi YY, Edmund NA, Somasundaram S, Moore DT, Orlowski RZ. (2004). Mol Pharmacol 66: 1478-1490.
Sparmann A, Bar-Sagi D. (2004). Cancer Cell 6: 447-458.
Stark LA, Dunlop MG. (2005). Mol Cell Biol 25: 5985-6004.
Subhashini J, Mahipal SV, Reddanna P. (2005). Cancer Lett 224: 31-43.
Tai YT, Li X, Tong X, Santos D, Otsuki T, Catley L et al. (2005). Cancer Res 65: 5898-5906.
Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. (2004). Oncogene 23: 9247-9258.
Tanaka A, Konno M, Muto S, Kambe N, Morii E, Nakahata T et al. (2005). Blood 105: 2324-2331.
Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. (2002). Cancer Cell 1: 493-503.
Thiery JP. (2002). Nat Rev Cancer 2: 442-454.
Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. (2003). Nature 424: 793-796.
Ueda Y, Richmond A. (2006). Pigment Cell Res 19: 112-124.
Wang CY, Cusack Jr JC, Liu R, Baldwin Jr AS. (1999a). Nat Med 5: 412-417.
Wang CY, Mayo MW, Baldwin Jr AS. (1996). Science 274: 784-787.
Wang W, Abbruzzese JL, Evans DB, Chiao PJ. (1999b). Oncogene 18: 4554-4563.
Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. (1999c). Clin Cancer Res 5: 119-127.
Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. (2006). Cancer Res 66: 2778-2784.
Webster GA, Perkins ND. (1999). Mol Cell Biol 19: 3485-3495.
Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin Jr AS. (2001). Mol Cell Biol 21: 8428-8436.
Yamamoto Y, Gaynor RB. (2001). J Clin Invest 107: 135-142.
Yin D, Zhou H, Kumagai T, Liu G, Ong JM, Black KL et al. (2005). Oncogene 24: 344-354.
Zaninoni A, Imperiali FG, Pasquini C, Zanella A, Barcellini W. (2003). Exp Hematol 31: 185-190.
Zhang JY, Green CL, Tao S, Khavari PA. (2004). Genes Dev 18: 17-22.
Zhou H, Du MQ, Dixit VM. (2005a). Cancer Cell 7: 425-431.
Zhou Y, Eppenberger-Castori S, Eppenberger U, Benz CC. (2005b). Endocr Relat Cancer 12(Suppl 1): S37-S46.
|
Language: | English.
|
Document Type: | Review.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0950-9232
|
NLM Journal Code: | onc, 8711562
|
Annotation(s) | |
|
|